Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
THRD Third Harmonic Bio Inc
- Stocks
- Healthcare
- NASDAQ: THRD
Price (delayed)
$5.27
Market cap
$237.82M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.23
Enterprise value
-$31.25M
Highlights
Third Harmonic Bio's debt has decreased by 20% YoY and by 6% QoQ
THRD's quick ratio is up by 33% since the previous quarter but it is down by 19% year-on-year
The equity fell by 4.4% QoQ but it rose by 3.5% YoY
The company's net income has shrunk by 81% YoY and by 18% QoQ
The company's EPS has shrunk by 64% YoY and by 13% QoQ
Key stats
What are the main financial stats of THRD
Market
Valuations
Earnings
Shares outstanding
45.13M
Market cap
$237.82M
Enterprise value
-$31.25M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.87
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$66.3M
Net income
-$53.45M
EBIT
-$53.45M
EBITDA
-$52.65M
Free cash flow
-$41.7M
Per share
Balance sheet
Liquidity
EPS
-$1.23
EPS diluted
-$1.23
Free cash flow per share
-$0.93
Book value per share
$6.04
Revenue per share
$0
TBVPS
$6.23
Total assets
$279.84M
Total liabilities
$7.22M
Debt
$3M
Equity
$272.62M
Working capital
$270.9M
Debt to equity
0.01
Current ratio
54.1
Quick ratio
53.33
Net debt/EBITDA
5.11
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-18.7%
Return on equity
-19.3%
Return on invested capital
-952.2%
Return on capital employed
-19.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
THRD stock price
How has the Third Harmonic Bio stock price performed over time
Intraday
0.38%
1 week
1.74%
1 month
1.93%
1 year
-60.26%
YTD
-48.79%
QTD
51.87%
Financial performance
How have Third Harmonic Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$66.3M
Net income
-$53.45M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 81% YoY and by 18% QoQ
THRD's operating income has dropped by 53% year-on-year and by 13% since the previous quarter
Price vs fundamentals
How does THRD's price correlate with its fundamentals
Growth
What is Third Harmonic Bio's growth rate over time
Valuation
What is Third Harmonic Bio stock price valuation
P/E
N/A
P/B
0.87
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has shrunk by 64% YoY and by 13% QoQ
The stock's price to book (P/B) is 42% less than its last 4 quarters average of 1.5
The equity fell by 4.4% QoQ but it rose by 3.5% YoY
Efficiency
How efficient is Third Harmonic Bio business performance
THRD's ROIC has plunged by 119% YoY and by 25% from the previous quarter
The return on equity has dropped by 77% year-on-year and by 17% since the previous quarter
THRD's return on assets has dropped by 76% year-on-year and by 17% since the previous quarter
Dividends
What is THRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for THRD.
Financial health
How did Third Harmonic Bio financials performed over time
THRD's quick ratio is up by 33% since the previous quarter but it is down by 19% year-on-year
THRD's current ratio is up by 32% since the previous quarter but it is down by 18% year-on-year
Third Harmonic Bio's debt is 99% lower than its equity
Third Harmonic Bio's debt has decreased by 20% YoY and by 6% QoQ
The equity fell by 4.4% QoQ but it rose by 3.5% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.